Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in moderate to severe chronic kidney disease
NCT00501046Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jul 2007
- Primary completion
- Oct 2011
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 12
01
Overview
A Phase 3 trial of activated charcoal in chronic kidney disease (CKD), sponsored by Mitsubishi Tanabe Pharma. Started Jul 2007; status: completed.
02
Drugs
activated charcoal
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00501046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501046.